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Diphenylphosphoryl azide (DPPA) mediated one-pot synthesis of Na-Fmoc/Bsmoc/Boc/Z-protected ureidopeptides and peptidyl
ureas as well as phenyl/succinimidyl (Na-urethane protected) methyl carbamates starting from Na-protected amino acids is reported.
The formation of an azide, its rearrangement and coupling with an amino component is accomplished in a sequence of one-pot oper-
ations. The protocol has incorporated urea linkages in a sterically hindered peptide.
 2008 Elsevier Ltd. All rights reserved.
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Peptide backbone modiﬁcation has developed into a
powerful tool to introduce desired structural motifs and
to enhance biological properties in peptidomimetics.1 The
urea linkage is the most common type of peptide bond
surrogate to be introduced into peptide sequences.2,3 The
metabolic stability and unique bonding properties of the
NH–CO–NH– moiety have resulted in its inclusion in
potent peptidyl conjugates and bioactive oligomers. Some
examples of peptidomimetics containing a urea moiety with
elevated biological properties are the TAR-binding frag-
ment of the Tat protein,4,5 HIV-1 proteases,6 c-secretase,7
aspartic acid protease,8 microbial alkaline proteinase inhib-
itors,9 and aspartic peptidases.10 The ureido analogs of
[Leu5]enkephalin,11 angiotensins,12 gastrin antagonists,
and protease inhibitors13,14 have been prepared. Natural
products containing urea linkages are also known.15 In
addition, urea linkages have been used as scaﬀolds to0040-4039/$ - see front matter  2008 Elsevier Ltd. All rights reserved.
doi:10.1016/j.tetlet.2007.12.060
* Corresponding author. Tel.: +91 8022961339.
E-mail address: hariccb@rediﬀmail.com (V. V. Sureshbabu).obtain new generation molecules like dendrimers and
self-assembling organic nanotubes.16 In this context, the
development of rapid and simpliﬁed synthetic procedures
for the insertion of a ureido linkage into peptide sequences
continues to receive attention.17
Current strategies to synthesize Na-protected urea-
linked peptides are predominantly based on Curtius and
Hoﬀmann rearrangements. Sureshbabu et al., reported an
elegant procedure for the synthesis of Fmoc protected
a-ureido peptides,18 oligoureas,19 and a variety of substi-
tuted phenyl-(9-ﬂuorenylmethoxycarbonylamino)methyl
carbamates20 through the classical Curtius rearrangement
employing a series of isocyanates derived from stable Na-
Fmoc amino acid azides.21 Guichard and co-workers,
reported the stepwise synthesis of N,N0-urea-linked oligo-
mers using O-succinimidyl (Na-urethane protected) methyl
carbamates.17 Lipton and co-workers, employed bis[triﬂu-
oroacetoxy]phenyliodine (PIFA) for synthesizing ureido-
peptides from Na-protected amino and peptide amides via
Hoﬀmann rearrangement.22 Appella and co-workers used
the same reagent to prepare 2,3-diaminopropionic acid
starting from Boc-Asn.23
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tius rearrangement24 involves a multi-step protocol
whereby an acid azide is prepared via a mixed anhydride
or acid chloride, its isolation and rearrangement into an
isocyanate followed by coupling with an amine. This proto-
col has considerable limitations such as the isolation of
potentially explosive acid azides, which cause handling
problems, and the inherently unstable isocyanates, espe-
cially those derived from Bsmoc, Boc, and Z-amino acids,
which can undergo partial degeneration even before cou-
pling with the amine. On the other hand, the protocol using
bis[triﬂuoroacetoxy]phenyliodine is particularly useful in
Boc and Z chemistry. Its utility in Fmoc chemistry is not
satisfactory due to the necessity of higher equivalents of
bases. Therefore, a simple, improved, and scalable protocol
which produces higher yields of the urea and which also
tolerates diﬀerent urethane protecting groups is desirable.
DPPA is used as an azide transfer reagent in organic
synthesis.25–33 Despite its extensive applications, to the best
of our knowledge, there are no reports on the synthesis of
Na-urethane protected ureidopeptides and peptidyl ureas
using DPPA.17,34,35 Herein, the properties of DPPA as a
carboxy activating and azido group transfer reagent are
exploited in obtaining ureido peptidomimetics. This proto-
col has advantages over previous methods as it circumvents
the pre-activation of the carboxylic group before reaction
with azide donors and isolation of unstable acid azidesN
H
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O
R2 DPPA
X-H2N
R3
CO2Y
 X=HCl or TsOH salt
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TH
R1
Scheme 1. Synthesis of Na
Table 1
Na-Fmoc/Bsmoc/Boc/Z-protected ureidopeptides and peptidyl ureas
Entry R1 R2 R3
1a Fmoc CH2OCH2C6H5 CH3
1b Fmoc CH2CH2COO
tBu CH2C6H5
1c Fmoc (CH2)4NHBoc CH(CH3)2
1d Fmoc CH2SCH2NHCOCH3 H
2ac Bsmoc CH2SCH2C6H5 CH3
2b Bsmoc CH2C6H5 CH(CH3)2
3a Boc CH2OCH2C6H5 H
3b Boc CH2COOCH2C6H5 CH3
3c Boc CH3 CH(CH3)2
4a Z CH2C6H5 CH3
4b Z CH(CH3)2 CH2C6H5
5a Fmoc-Leu CH3 CH2C6H5
5b Fmoc-Ser(OBn) CH2C6H5 CH3
5c Boc-Pro CH(CH3)2 CH(CH3)C2
5d Z-Val CH(CH3)CH2CH3 CH(CH3)2
a ESI MS [M+H].
b MALDI TOF [M+Na].
c HRMS: found, 556.1185 (M+Na); calcd, 556.1188 (M+Na).and isocyanates. In addition, the complete sequence of
functional group transformations can be accomplished in
one-pot.
2. Results and discussions
In a typical reaction, a solution of Na-Fmoc/Bsmoc/
Boc/Z-amino acid or peptide acid in THF was maintained
at 0 C. To this, equimolar quantities of diisopropylethyl-
amine (DIEA) and DPPA were added successively. The
reaction mixture was stirred at 0 C for 20 min followed
by addition of the amino acid ester. The resulting reaction
mixture was subjected to reﬂux/ultrasonication/microwave
irradiation. The in situ generated isocyanate immediately
reacted with the amino acid ester to aﬀord the required
ureas 1a–4b and 5a–d (Scheme 1, Table 1). IR analysis of
the reaction mixture without addition of the amino/phenol
component revealed a distinct isocyanate peak at around
2300 cm1. Product isolation in most cases was straight-
forward as they precipitated from the reaction mixture as
solids. However, some of the Boc, Bsmoc, and Z-ureido-
peptides did not precipitate and required a simple work-
up. The Fmoc-ureidopeptides/carbamates were recrystal-
lized as pure crystalline solids using DMSO/water (8:2).
When the reaction was carried out under microwave irradi-
ation, the Na-protected amino acids were dissolved in a
minimum amount of THF and then diluted with tolueneN
H
N
H
N
H
O
OY
O
R2 R3, DIEA
F
R1
1a-d; 2a,b; 3a-c; 4a,b; 5a-d
-protected urea esters.
Y Mp (C) Yield (%) Mass
Method
A B C
CH3 184 94 95 79 518.2
a
Bn 147 89 85 71 616.2a
CH3 180 92 95 80 597.3
a
Bn 175 72 78 70 577.2a
CH3 148 78 83 75 534.1
a
Et 182 70 75 74 530.2a
CH3 123 78 77 72 382.2
a
Et 140 80 75 70 438.2a
CH3 170 90 80 75 318.2
a
CH3 169 86 80 70 400.2
a
Bn 197 92 89 82 504.2a
CH3 147 90 85 — 624.3
b
Bn 173 91 92 — 764.3b
H5 Bn 175 75 78 — 556.3
b
Bn 192 80 85 — 592.3b
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Also, replacing THF with other solvents such as CH2Cl2,
CHCl3, and DMF gave no signiﬁcant changes in the prod-
uct yields. A number of Na-Fmoc/Boc/Z-protected ureid-
odipeptide esters were synthesized in 71–94% yields.
Ureidopeptides, 2a,b, containing the highly base-sensitive
Bsmoc group were also prepared in good yields. Urea-
linked dipeptides with at least one side-chain functionalized
amino acid were synthesized in about 75% yields via the
described procedure. Moreover, NMR analysis of the
products revealed the entire protocol to be free from
epimerization.36 Though all the three described methods
worked well for the synthesis of ureidopeptides, better
results were obtained when the reaction was carried out
under thermal and ultrasonication in terms of purity and
yield.
The protocol was also useful to synthesize Na-urethane
protected amino methyl carbamates, which are known to
be stable precursors for insertion of a urea moiety. WhenHN
OH
PG
O
R
DPPA, D
THF
+ HO-Y
Scheme 2. Synthesis of Na-protec
Table 2
Active phenyl/succinimidyl Na-Fmoc/Boc/Z-protected methyl carbamates
Entry PG R Y
6a Fmoc CH2C6H5 C6F5
6b Fmoc CH(CH3)C2H5 C6H2Cl3
b
6c Fmoc CH2COO
tBu p-C6H4NO
6d Boc CH2CH(CH3)2 C4H4NO2
c
6e Z CH(CH3)CH2CH3 C6Cl5
a ESI MS.
b 2,4,5-Trichlorophenyl.
c N-Hydroxysuccinimidyl.
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Scheme 3. Synthesis of urea linkaN-protected amino acids were subjected to similar reaction
conditions with the addition of phenol/N-hydroxy-
succinimide, carbamates 6a–e were obtained in yields of
78–95% (Scheme 2, Table 2). It is noteworthy that our
attempts to prepare these carbamates in a one-pot reaction
using PIFA resulted in lower yields.
Finally, the versatility of the reported protocol for the
insertion of a urea linkage in large peptides was demon-
strated by the incorporation of the –NH–CO–NH– moiety
between the 4th and 5th positions of the b-sheet octapep-
tide Boc-Leu-Aib-Val-b-Ala-c-Abu-Leu-Aib-Val-OMe.37
The octapeptide length was maintained constant by replac-
ing c-Abu with b-Ala. The synthesis of 9 (Scheme 3) was
accomplished by coupling of Boc-Leu-Aib-Val-b-Ala-OH
7 with b-Ala-Leu-Aib-Val-OMe 8 in the presence of an
equimolar quantity of DPPA and DIEA under ultrasonica-
tion. After simple work-up and recrystallization, 9 was
obtained in 84% yield and characterized using 1H NMR
and MALDI-mass spectrometry.HN N
H
PG O
O
Y
R
IEA
6a-e
Y=C6F5, C6H2Cl3, p-C6H4NO2
C4H4NO2, C6Cl5
ted active methyl carbamates.
Mp (C) Yield (%) Massa [M+H]
Method
A B
163 92 90 569.16
116 95 91 547.10
2 136 87 89 548.25
107 79 78 344.16
162 85 83 526.95
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ge-containing octapeptide 9.
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In conclusion, we have developed a useful one-pot pro-
tocol for the incorporation of a urea moiety in Na-urethane
protected peptides employing DPPA. Fmoc/Bsmoc/Boc/Z-
protected ureidopeptide esters and various active carb-
amates have been prepared in good yields without
epimerization.
4. General experimental procedure for the preparation of
ureido peptides, methyl carbamates, and peptidyl ureas
4.1. Method A: thermal
To a solution of Na-protected amino acid/peptide acid
(1.0 mmol) in THF, DPPA (1.0 mmol) and DIEA
(1.0 mmol) were added successively at 0 C and the reac-
tion stirred for 20 min. To this, amino acid ester salt
(1.0 mmol) neutralized with N-methylmorpholine (NMM)
(1.0 mmol) in THF was added and the reaction mixture
reﬂuxed for about 30 min until completion (as monitored
by TLC). The precipitated crude ureido peptides were iso-
lated by simple ﬁltration and recrystallized using DMSO/
water (8:2). In the case of several Boc/Z/Bsmoc-protected
products, simple workup was required. The solvent was
removed in vacuo and the reaction mixture was taken into
ethyl acetate. The organic layer was washed with 10% citric
acid solution, NaHCO3 (10%) solution, brine, and dried
over anhydrous Na2SO4. The solvent was removed under
reduced pressure to aﬀord the product, which was recrys-
tallized from DMSO/ water (8:2).
4.2. Method B: ultrasonication at ambient temperature
To a solution of Na-protected amino acid/peptide acid
(1.0 mmol) in THF, DPPA (1.0 mmol) and DIEA
(1.0 mmol) were added at 0 C and the reaction stirred
for 20 min. To this, amino acid ester (1.0 mmol) neutral-
ized with NMM (1.0 mmol) in THF was added and the
reaction mixture was subjected to ultrasonic irradiation
(35 kHz, ELMA, TRANSSONIC 310/H) at ambient tem-
perature for 20 min, until the reaction was complete. The
resulting products were isolated using the procedure
described in method A.
4.3. Method C: microwave irradiation
To a solution of Na-protected amino acid/peptide
acid (1.0 mmol) in THF/toluene mixture, DPPA (1.0 mmol)
and DIEA (1.0 mmol) were added at 0 C and the reaction
stirred for 20 min. To this, amino acid ester (1.0 mmol)
neutralized with NMM (1.0 mmol) in THF was added
and then the reaction mixture was exposed to microwave
irradiation (Samsung M1739N oven with a frequency of
2450 MHz, at 60% of the total power output, i.e., 720 W)
until the reaction was complete. The reaction was worked
up as described in method A.5. Selected spectral data
5.1. Na-Boc-Ser (OBn)-w(NH–CO–NH)-Gly-OMe ð3aÞ
1H NMR (300 MHz, DMSO-d6): d 1.35 (s, 9H), 3.60 (s,
3H), 3.52–3.75 (m, 4H), 4.48 (s, 2H), 5.32 (m, 1H), 6.23 (m,
2H), 6.82 (t, J = 10.4 Hz, 1H), 7.30–7.42 (m, 5H): 13C
NMR (100 MHz, DMSO-d6): d 28.5, 51.7, 57.7, 63.7,
65.0, 71.9, 78.0, 126.6, 129.3, 130.5, 138.0, 155.3, 156.8,
174.5. ESI MS: m/z 382.2 [M+H]+. Anal. Calcd for
C18H27N3O6: C, 56.68; H, 7.15; N, 11.02. Found: C,
56.38; H, 7.20; N, 11.10.
5.2. Na-Z-Phe-w(NH–CO–NH)-Ala-OMe ð4aÞ
1H NMR (300 MHz, DMSO-d6): d 1.50 (d, J = 6.2 Hz,
3H), 2.92 (d, J = 6.7 Hz, 2H), 3.52 (s, 3H), 4.12 (m, 1H),
4.80 (s, 2H), 5.21 (br m, 1H), 6.45 (d, J = 7.2 Hz, 1H),
6.57 (d, J = 7.4 Hz, 1H), 7.10–7.40 (m, 10H), 7.79 (d,
J = 6.9 Hz, 1H). 13C NMR (100 MHz, DMSO-d6): d
17.0, 41.2, 50.2, 51.1, 63.5, 65.3, 126.0, 127.4, 127.6,
128.0, 128.6, 129.0, 129.8, 138.6, 141.2, 156.1, 158.5,
171.9. ESI MS: m/z 400.2 [M+H]+.
5.3. Fmoc-Leu-Ala-w(NH–CO–NH)-Phe-OMe ð5aÞ
1H NMR (300 MHz, DMSO-d6) d 0.85–0.90 (m, 6H),
1.17 (d, J = 6.3 Hz, 3H), 1.35 (m, 2H), 1.40–1.60 (m,
1H), 2.95 (d, J = 6.7 Hz, 2H), 3.15 (m, 2H), 3.60 (s, 3H),
3.95 (m, 1H), 4.20–4.45 (m, 3H), 5.36 (br, 1H), 6.50 (m,
2H), 7.15–7.50 (m, 9H), 7.75 (d, J = 7.1 Hz, 2H), 7.90 (d,
J = 7.1 Hz, 2H), 8.15 (m, 1H). 13C NMR (100 MHz,
DMSO-d6): d 17.5, 22.0, 23.7, 25.0, 37.9, 41.5, 47.6, 49.5,
52.3, 54.0, 65.3, 67.3, 120.1, 125.3, 126.7, 127.3, 127.9,
128.5, 129.3, 137.8, 141.5, 144.0, 156.7, 169.1, 172.1,
173.6. MALDI-TOF MS: m/z observed 623.3 [M+Na].
5.4. Bsmoc-Phe-w(NH–CO–NH)-Val-OEt ð2bÞ
1H NMR (300 MHz, DMSO-d6) d 0.95 (d, J = 7.8 Hz,
6H), 1.13 (t, J = 8.1 Hz, 3H), 1.81 (m, 1H), 2.98 (m, 2H),
4.28 (s, 2H), 4.48 (m, 2H), 4.51 (m, 1H), 6.12 (d,
J = 6.5 Hz, 1H), 6.30 (m, 1H), 6.9–7.7 (m, 10H), 9.0 (m,
2H) 13C NMR (100 MHz, DMSO-d6): d 15.12, 18.24,
38.23, 41.35, 58.91, 60.12, 69.22, 70.15, 112.53, 118.75,
125.29, 126.21, 127.21, 128.12, 129.82, 132.82, 133.53,
135.58, 139.23, 141.20, 155.45, 160.52, 175.18. HRMS:
found, 529.1881 [M+Na]; calcd, 529.1883 [M+Na].
5.5. p-Nitrophenyl-{1-(9-ﬂuorenylmethoxycarbonylamino)-
2-[tert-butoxycarbonyl]methyl}carbamate ð6cÞ
1H NMR (300 MHz, DMSO-d6): d 1.45 (s, 9H), 2.45 (m,
2H), 4.20–4.35 (m, 4H), 6.65 (d, J = 7.4 Hz, 1H), 7.20–8.14
(m, 13H). 13C NMR (100 MHz, DMSO-d6): d 28.0, 37.9,
47.3, 49.1, 66.7, 81.6, 120.1, 121.8, 125.1, 127.0, 127.7,
141.4, 143.8, 144.6, 153.7, 155.6, 156.8, 171.3. MS
1412 V. V. Sureshbabu et al. / Tetrahedron Letters 49 (2008) 1408–1412(MALDI-TOF) m/z observed: 570.0 [M+Na]+, 586.2
[M+K]+. Anal. Calcd for C29H29N3O8: C, 63.61; H, 5.34;
N, 7.67. Found: C, 63.52; H, 5.22; N, 7.56.
5.6. Compound 9
1H NMR (400 MHz, DMSO-d6) d 0.75–0.95 (m, 24H),
1.39 (s, 9H), 1.52 (m, 6H), 1.62 (m, 2H), 1.69–1.85 (m,
12H), 1.97 (m, 1H), 2.28 (m, 2H), 2.98 (m, 2H), 3.15–
3.21 (m, 3H), 3.85–3.97 (m, 2H), 4.03–4.15 (m, 3H), 4.59
(m, 1H), 6.87–6.96 (m, 2H), 7.01–7.22 (m, 3H), 7.59–7.85
(m, 3H), 8.15 (s, 1H), 8.21 (s, 1H). MALDI-TOF MS:
m/z observed 906.5 [M+Na], 922.5 [M+K]. HRMS: found,
906.5653 [M+Na]; calcd, 906.5640 [M+Na].
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